We sought to test the hypotheses that plasma NfL levels are associated with (a) APOE ε4 allelic dose, (b) FDG-PET and MRI biomarkers of neurodegeneration in brain regions preferentially affected by AD, and (c) lower recall memory test scores. This evidence concerns the gene APOE and Alzheimer disease.